These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 2427956)

  • 1. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
    Tschopp J; Masson D; Stanley KK
    Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perforin. A family of killer proteins.
    Stanley K; Luzio P
    Nature; 1988 Aug; 334(6182):475-6. PubMed ID: 3261390
    [No Abstract]   [Full Text] [Related]  

  • 3. Homology of perforin to the ninth component of complement (C9).
    Shinkai Y; Takio K; Okumura K
    Nature; 1988 Aug; 334(6182):525-7. PubMed ID: 3261391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
    Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
    Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of cytolysis by complement and by cytolytic lymphocytes.
    Podack ER
    J Cell Biochem; 1986; 30(2):133-70. PubMed ID: 2422185
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
    Jiang S; Persechini PM; Perussia B; Young JD
    J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and function of human perforin.
    Lichtenheld MG; Olsen KJ; Lu P; Lowrey DM; Hameed A; Hengartner H; Podack ER
    Nature; 1988 Sep; 335(6189):448-51. PubMed ID: 3419519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G; Malorni W; Donelli G
    Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of cytotoxicity: comparison of complement and killer lymphocytes.
    Müller-Eberhard HJ; Zalman LS; Chiu FJ; Jung G; Martin DE
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():28-34. PubMed ID: 3612651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylcholine acts as a Ca2+-dependent receptor molecule for lymphocyte perforin.
    Tschopp J; Schäfer S; Masson D; Peitsch MC; Heusser C
    Nature; 1989 Jan; 337(6204):272-4. PubMed ID: 2783478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of granule proteins in T-cell-mediated cytolysis.
    Krähenbühl O; Tschopp J
    Nat Immun Cell Growth Regul; 1990; 9(4):274-82. PubMed ID: 2215515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pore-forming protein (perforin) of cytolytic T lymphocytes is immunologically related to the components of membrane attack complex of complement through cysteine-rich domains.
    Young JD; Liu CC; Leong LG; Cohn ZA
    J Exp Med; 1986 Dec; 164(6):2077-82. PubMed ID: 3537195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Channel-forming proteins of man and amoebae.
    Müller-Eberhard HJ
    Behring Inst Mitt; 1992 Apr; (91):138-44. PubMed ID: 1381916
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of lymphocyte-mediated lysis.
    Joag S; Zychlinsky A; Young JD
    J Cell Biochem; 1989 Mar; 39(3):239-52. PubMed ID: 2651463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities.
    Tschopp J; Masson D; Schäfer S; Peitsch M; Preissner KT
    Biochemistry; 1988 May; 27(11):4103-9. PubMed ID: 2458130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of homologous restriction factor does not affect CTL-mediated cytolysis.
    Krähenbühl OP; Peter HH; Tschopp J
    Eur J Immunol; 1989 Jan; 19(1):217-9. PubMed ID: 2784107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
    Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
    J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
    Brannen CL; Sodetz JM
    Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of refolding conformers of complement protein C9 during insertion into membranes.
    Laine RO; Esser AF
    Nature; 1989 Sep; 341(6237):63-5. PubMed ID: 2475785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine esterase in cytolytic T lymphocytes.
    Pasternack MS; Verret CR; Liu MA; Eisen HN
    Nature; 1986 Aug 21-27; 322(6081):740-3. PubMed ID: 3489187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.